CellWell record HH-399835
Use of progestogens and the risk of intracranial meningioma: national case-control study
Roland N; Neumann A; Hoisnard L; Duranteau L; Froelich S; Zureik M; Weill A
BMJ (Clinical research ed.) ยท 2024
In plain language
In a French national case-control study, prolonged use of medrogestone, injectable medroxyprogesterone acetate, or promegestone was associated with higher odds of intracranial meningioma, while intrauterine levonorgestrel showed no excess risk.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-399835
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.